Alcon to Acquire Tear Film Innovations for its iLux Medical Device

 Alcon to Acquire Tear Film Innovations for its iLux Medical Device

Alcon to Acquire Tear Film Innovations for its iLux Medical Device

Shots:
  • Alcon acquires Tear Film in all stock transaction with its iLux device, used for the treatment of Meibomian Gland Dysfunction
  • The focus of the acquisition is to strengthen and expand Alcon’s ocular products in the US and Canada, including Tear’s iLux device for dry eye relief
  • The iLux Device is an easy-to-use, portable medical device that directly helps in visualizing meibomian gland orifices indicated for used for Meibomian Gland Dysfunction and has also received FDA’s 510 (k) approval

Click here to read full press release/ article | Ref: Alcon | Image: Bio Tuesdays

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post